Elisha M. Wachman, MD
Associate Professor
Boston University School of Medicine
Dept of Pediatrics
Neonatology

MD, Boston University School of Medicine




Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research interests include the genetics and epigenetics of NAS, breastfeeding in the setting of maternal substance use disorders, and the use of non-pharmacologic care methods to improve NAS outcomes. She is the neonatal lead of the Massachusetts (MA) neoQIC NAS Quality Improvement Collaborative. She was a site investigator in a NIDA funded clinical trial comparing the short-term and long-term outcomes of methadone versus morphine for NAS and is currently the principal investigator of a NICHD funded study examining the safety, efficacy, pharmacokinetics, pharmacogenomics, and long-term maternal and infant outcomes of extended-release naltrexone for pregnant women with opioid use disorder.

2018 America's Essential Hospitals Gage Award



Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with…
09/17/2018 - 05/31/2023 (PI)
NIH-NICHD
1R01HD096798-01

Neonatal Abstinence Syndrome (NAS) Research and Quality Improvement Program
12/14/2016 - 08/31/2018 (PI)
Massachusetts Health Policy Commission



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Wachman EM, Minear S, Hirashima M, Hansbury A, Hutton E, Shrestha H, Combs G, Barry K, Slater C, Stickney D, Walley AY. Standard Fixed-Schedule Methadone Taper Versus Symptom-Triggered Methadone Approach for Treatment of Neonatal Opioid Withdrawal Syndrome. Hosp Pediatr. 2019 Jul 03.View Related Profiles. PMID: 31270130.
     
  2. Wachman EM. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome? J Addict Med. 2019 May 28. PMID: 31149916.
     
  3. Jones HE, Kaltenbach K, Benjamin T, Wachman EM, O'Grady KE. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions. J Addict Med. 2019 Mar/Apr; 13(2):90-92. PMID: 30334926.
     
  4. Wachman EM, Farrer LA. The genetics and epigenetics of Neonatal Abstinence Syndrome. Semin Fetal Neonatal Med. 2019 Apr; 24(2):105-110.View Related Profiles. PMID: 30709700.
     
  5. Wachman EM, Werler MM. Pharmacologic Treatment for Neonatal Abstinence Syndrome: Which Medication Is Best? JAMA Pediatr. 2019 Jan 22.View Related Profiles. PMID: 30667482.
     
  6. Rose-Jacobs R, Trevino-Talbot M, Lloyd-Travaglini C, Cabral HJ, Vibbert M, Saia K, Wachman EM. Could prenatal food insecurity influence neonatal abstinence syndrome severity? Addiction. 2019 Feb; 114(2):337-343.View Related Profiles. PMID: 30422365.
     
  7. Howard MB, Wachman E, Levesque EM, Schiff DM, Kistin CJ, Parker MG. The Joys and Frustrations of Breastfeeding and Rooming-In Among Mothers With Opioid Use Disorder: A Qualitative Study. Hosp Pediatr. 2018 Dec; 8(12):761-768.View Related Profiles. PMID: 30401783.
     
  8. Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FNU, Shaw D, Saia K, Schiff DM. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity. Drug Alcohol Depend. 2018 11 01; 192:45-50.View Related Profiles. PMID: 30205307.
     
  9. Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 12; 203:34-40.e1.View Related Profiles. PMID: 30170857.
     
  10. Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA Pediatr. 2018 Aug 01; 172(8):741-748. PMID: 29913015.
     
Showing 10 of 31 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 31 publications over 9 distinct years, with a maximum of 9 publications in 2018

YearPublications
20102
20111
20131
20142
20153
20164
20174
20189
20195
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Neonatal Abstinence Syndrome
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Wachman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department